Neurones (XPAR:NRO) Total Stockholders Equity: €400.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:NRO Neurones XPAR:NRO
100 GF Score
Price €36.85
GF Value €50.70
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Neurones Total Stockholders Equity?

Neurones XPAR:NRO -0.67% 100 Total Stockholders Equity is €400.0 Mil as of Dec. 2025. GuruFocus rates XPAR:NRO with a GF Score™ of 100/100 and a GF Value™ of €50.70 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Neurones's Total Stockholders Equity for the quarter that ended in Dec. 2025 was €400.0 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Neurones's Book Value per Share for the quarter that ended in Dec. 2025 was €16.45. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Neurones's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.09.

Neurones  (XPAR:NRO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Neurones's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(399.98-0)/24.315
=16.45

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Neurones's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(10.944 + 26.019) / 399.98
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurones Total Stockholders Equity Related Terms

Neurones Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Neurones's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurones Total Stockholders Equity Chart

Neurones Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 311.56 330.58 355.75 378.10 399.98

Neurones Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 355.75 349.78 378.10 371.19 399.98
XPAR:NRO
100GF Score
Neurones XPAR:NRO
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of €400.0 Mil mean?
Neurones (XPAR:NRO) has a Total Stockholders Equity of €400.0 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Neurones and its competitors.
Is Neurones' Total Stockholders Equity too high?
Neurones' current Total Stockholders Equity is €400.0 Mil. Overall, Neurones has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neurones' Total Stockholders Equity compare to IBM and ACN?
Neurones' Total Stockholders Equity of €400.0 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Software company?
A good Total Stockholders Equity depends on the Software industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Neurones and its competitors. Neurones's current Total Stockholders Equity is €400.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurones stock overvalued right now?
Based on GuruFocus' analysis, Neurones (XPAR:NRO) is currently considered Modestly Undervalued. The stock's GF Value™ is €50.70, compared to a current price of €36.85 — trading 27.3% below its estimated fair value. The current Total Stockholders Equity is €400.0 Mil. Neurones' overall GF Score™ is 100/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Neurones (XPAR:NRO), the current Total Stockholders Equity is €400.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neurones (XPAR:NRO) Overvalued in 2026?

Based on GuruFocus' analysis, Neurones stock appears to be undervalued. The current stock price of €36.85 is trading 27.3% below its estimated GF Value™ of €50.70. GuruFocus considers Neurones to be Modestly Undervalued.

Key valuation signals for XPAR:NRO:

  • Total Stockholders Equity: €400.0 Mil
  • GF Value™: €50.70 vs. price of €36.85 (27.3% below fair value)
  • GF Score™: 100/100 with 2 warning signs

No single metric tells the full story. See the XPAR:NRO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neurones Business Description

Other Exchanges 0GX2:UKNE9:Germany
Address 205 Avenue Georges Clemenceau, Immeuble Le Clemenceau 1 Building, Nanterre, FRA, 92024
Neurones is active in Consulting and Digital Services, with activities including Digital Transformation, Overall Offer, Infrastructure Hub, Applications Hub, Consulting Division, Managed Services, and Service Centers. It also conducts IT development, pre-sales activities, management of fixed-price projects, technical assistance, infrastructure operations, and cybersecurity, and provides an internal platform for multi-LLM assistants, including Microsoft Copilot, ChatGPT, Gemini, Claude, and Mistral. Its segments are Infrastructure Services, Application Services, and Consulting. Infrastructure Services generates the majority of revenue and includes Cloud, Infrastructure Management, DevOps, Cybersecurity, User Support, IT Service Management, Information System Governance, and Automation.
100GF Score

Get the complete analysis for XPAR:NRO

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€36.85
Price
€50.70
GF Value